From: Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C
Variablesa | No fibrosis (F0) | Liver fibrosis (F1‑F3) | Cirrhosis (F4) | ||||||
---|---|---|---|---|---|---|---|---|---|
Group Ib (n = 63) | Group IIb (n = 32) | *P value | Group Ib (n = 50) | Group IIb (n = 40) | *P value | Group Ib (n = 18) | Group IIb (n = 46) | *P value | |
Age (year) | 32.05 ± 0.91 | 32.50 ± 0.92 | 0.732 | 40.58 ± 1.55 | 46.60 ± 1.66 | 0.011* | 55.89 ± 3.87 | 53.23 ± 2.50 | 0.570 |
ALT (U/L) | 19.50 ± 0.90 | 25.75 ± 1.51 | < 0.001* | 49.28 ± 2.36 | 60.05 ± 4.80 | 0.027* | 60.11 ± 5.64 | 70.91 ± 4.39 | 0.040* |
AST (U/L) | 19.42 ± 0.85 | 29.63 ± 2.11 | < 0.001* | 49.20 ± 2.94 | 66.45 ± 6.14 | 0.010* | 65.17 ± 6.66 | 70.46 ± 5.52 | 0.046* |
T. bilirubin (mg/dl) | 0.58 ± 0.03 | 0.86 ± 0.04 | < 0.001* | 1.73 ± 0.23 | 1.84 ± 0.56 | 0.868 | 1.72 ± 0.44 | 1.81 ± 0.19 | 0.817 |
Albumin (g/L) | 4.25 ± 0.07 | 3.45 ± 0.08 | < 0.001* | 3.57 ± 0.30 | 3.41 ± 0.21 | 0.666 | 3.23 ± 0.20 | 2.89 ± 0.12 | 0.136 |
Platelets (109/L) | 239.5 ± 7.2 | 240.7 ± 8.4 | 0.920 | 200.2 ± 35.1 | 143.9 ± 24.5 | 0.224 | 245.5 ± 121.5 | 110.7 ± 13.6 | 0.025* |
AFP (U/L) | 1.04 ± 0.08 | 1.70 ± 0.05 | < 0.001* | 26.38 ± 3.93 | 71.04 ± 19.71 | 0.003* | 36.14 ± 4.87 | 106.96 ± 22.39 | 0.030* |